Breaking News Headlines Today | Ground News

See every side of every news story

ajmc.com image

News from ajmc.com

ajmc.com’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

ajmc.com’s aggregated factuality score is Unknown. Factuality is assigned by combining fact check, credibility, and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about ajmc.com

Where is ajmc.com located?ajmc.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top ajmc.com News

Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump — ANGELA WEISS/AFP via Getty Images via Getty Images

Drug Prices · United States

Pfizer agrees to lower prescription drug costs for Medicaid in a deal with Trump

50% Center coverage: 321 sources

Pfizer has agreed to lower the cost of prescription drugs for Medicaid under a deal struck with the Trump administration, President Donald Trump said Tuesday as he promised similar deals with other drugmakers under the threat of tariffs.See the Story

FDA Approves Maintenance Combo for Small Cell Lung Cancer

FDA · United States

FDA Approves Maintenance Combo for Small Cell Lung Cancer

80% Center coverage: 5 sources

(MedPage Today) -- The FDA approved lurbinectedin (Zepzelca) plus either atezolizumab (Tecentriq) or atezolizumab and hyaluronidase (Tecentriq Hybreza) as first-line maintenance therapy for extensive-stage small cell lung cancer, the agency announced...See the Story

FDA Under Pressure From Right After Abortion Pill Approval

Mifepristone · United States

FDA Under Pressure From Right After Abortion Pill Approval

67% Center coverage: 3 sources

The anti-abortion movement’s patience with the Food and Drug Administration (FDA) is wearing thin following the agency’s recent approval of a second generic version of mifepristone, one of two drugs taken for a medication abortion. President Trump repeatedly pledged during the campaign last year that he would leave abortion policy to the states, but…See the Story

Breaking News Topics Related to ajmc.com